WithdrawnNCT03502551
ED Treatment of Suicidal Patients With Ketamine Infusion
Medication studyAges 18+United StatesSuicide prevention
Understand this study
Who could participate?
Listed age limits: from 18 years.
What will I do during this study?
The study group receives ketamine as a study medication.
- Listed locations
- SacramentoSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: April 1, 2019
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- University of California, Davis
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT03502551
- Official title
Show the full official title
ED Treatment of Suicidal Patients With Ketamine Infusion
Recruitment & locations
WithdrawnSacramento
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is University of California, Davis, a university.
Does this study involve medication?
Yes. The study involves medication, including ketamine.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
